NOVOZYMES A/S SPONS.ADR 1 (NZM) — Defensive Interval Ratio

Latest as of March 2026: 227 days

NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Defensive Interval Ratio of 227 days as of March 2026. Defensive assets of €758.60 Million (cash €-, short-term investments €2.20 Million, receivables €756.40 Million) cover 227 days of daily cash needs of €3.35 Million/day. Check NOVOZYMES A/S SPONS.ADR 1 (NZM) tangible net worth to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

227 days
Days of operational coverage

Defensive Assets

€758.60 Million
Cash + ST Investments + Receivables

Daily Cash Need

€3.35 Million
Current Liabilities ÷ 365

Current Liabilities

€1.22 Billion
EUR

NOVOZYMES A/S SPONS.ADR 1 Defensive Interval Ratio (2021–2025)

This chart shows how NOVOZYMES A/S SPONS.ADR 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 227 days, meaning defensive assets of €758.60 Million can fund 227 days of operations without new revenue. Also explore NZM year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NZM market cap.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 98 days €736.80 Million €7.51 Million/day €- €20.30 Million ▼ -126 days
2024 225 days €669.60 Million €2.98 Million/day €- €4.00 Million ▲ +36 days
2023 188 days €502.10 Million €2.66 Million/day €- €5.40 Million ▲ +3 days
2022 185 days €474.30 Million €2.56 Million/day €- €10.74 Million ▼ -9 days
2021 194 days €406.47 Million €2.09 Million/day €- €10.08 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)